Health care and medical care<\/h2>\n
Medical care treats disease once it has appeared. Health care works on the condition of the body itself, so that it is better able to resist illness and to repair. Both are necessary, and they are not the same work.<\/p>\n
In psoriasis the division is unusually visible, because the disease is on the outside where it can be watched. Medical care can quiet it, and quiet it quickly. What it does not do is remove the reason the immune system is behaving this way, which is why the quieting has to continue indefinitely and why the drugs get stronger over the years rather than weaker.<\/p>\n
The practical sequence follows from that, and it does not change. Relief first, from whatever is currently working. Correction alongside it. And then, as symptoms settle and repeat testing confirms it, the medicines come down. In that order, and never the other way round.<\/p>\n
What “reversal” means here \u2014 and what it does not<\/h2>\n
Reversal here means a measured, sustained reduction in the inflammation driving the disease, and in the load that provokes it<\/strong> \u2014 with the skin, the joints and the blood markers all moving together. In practice that is the visible extent and thickness of the lesions, the itching and the scaling, joint pain and morning stiffness, and a set of things that can be counted: hs-CRP, CRP and ESR, the full blood count, liver and kidney function, fasting insulin, and the ratio of lean mass to fat mass.<\/p>\n It is not a claim that the tendency has gone.<\/strong> The honest limit here is structural, and it is the same limit as in every condition this practice works with:<\/p>\n Naming the limit is what makes the rest of it believable.<\/p>\n It is an autoimmune disease<\/strong>, and the skin is where it becomes visible. That distinction is not a technicality; it decides what is worth treating.<\/p>\n The disease reaches well past the skin. It affects the nails<\/strong>. It affects the joints<\/strong>, and that is the commonest extension of it. It can affect the eyes<\/strong> \u2014 uveitis, and in the worst cases corneal ulceration. And alongside it sit the metabolic conditions that travel with chronic inflammation: fatty liver, insulin resistance, obesity, high triglycerides, raised blood pressure.<\/p>\n The skin itself is worth understanding as part of the immune system rather than as a separate organ. It is the boundary of the body \u2014 the wall that decides what is inside and what is outside. A disease of the immune system showing up first at that boundary is not a coincidence.<\/p>\n A great many people assume the joints follow the skin. Frequently they do not. Joint pain, morning stiffness, a swollen finger or toe, or a painful heel can arrive years before a single patch appears \u2014 and because there is nothing on the skin to point at, the joint problem gets treated as something else entirely.<\/p>\n The practical consequence is worth stating plainly. Somebody with unexplained joint pain and a family history of psoriasis is a different patient from somebody with unexplained joint pain and no such history<\/strong>, and the family history is a question that often does not get asked.<\/p>\n Psoriasis runs in families, and patients are frequently told this in a way that sounds like a sentence being passed. It should not.<\/p>\n What is inherited is a susceptibility. What decides whether that susceptibility becomes an active disease is largely environmental \u2014 the food, the toxin load, the sleep, the stress, the state of the gut. Those are the parts that can be changed. The genetics cannot be controlled; the epigenetics, which is to say the environment, can \u2014 and in a disease like this the environment matters more.<\/strong><\/p>\n It is also, emphatically, not contagious<\/strong>. That needs saying because patients are treated as though it were, and because it is one of the cruellest parts of the illness.<\/p>\n The immune system does two jobs. One is defence<\/strong> \u2014 inflammation, the response that attacks what does not belong. The other is healing<\/strong> \u2014 repair at cell level, rebuilding what has been damaged. A working immune system holds those two in balance.<\/p>\n In psoriasis the defence half is running far too hot and the healing half cannot keep up. The immune cells stop distinguishing the body’s own skin cells from something foreign, and they attack them. The inflammatory signalling that follows drives the visible disease.<\/p>\n The scaling itself has a precise explanation. A skin cell normally takes twenty-eight to thirty days<\/strong> to travel from the basal layer to the surface and be shed. In psoriasis that journey is completed in four to five days<\/strong>. The cells arrive at the surface immature and in enormous numbers, and that is what the patient is sweeping off the bed.<\/p>\n Two consequences follow, and both matter for what a patient should expect. Because the skin’s own cycle is about thirty days, meaningful clearing of the skin takes about thirty days<\/strong> \u2014 it cannot be honestly promised sooner. But immune cells live only four to five days, and in active disease sometimes three or four<\/strong>. Correct what those cells are being built from, and the immune picture starts changing within a week, well before the skin has caught up.<\/p>\n The gut is the body’s other boundary \u2014 a far larger one than the skin, carrying its own population of bacteria and the food that has not yet been broken down.<\/p>\n In psoriasis it is repeatedly involved. Mouth ulcers are common in these patients, and the mouth is simply the visible end of a tube that runs to the other end of the body; where there is ulceration there, there is often ulceration further along, and material crossing into the body that should not. That is one of the mechanisms by which the immune system is provoked in the first place.<\/p>\n It is also why psoriasis so often flares after an infection<\/strong> \u2014 a bout of tonsillitis, a streptococcal or staphylococcal infection. That pattern is well recognised, and it is the clearest everyday evidence that this is an immune disease rather than a skin complaint.<\/p>\n Of the nutrients that matter here, the fats matter most, because they are the controllers.<\/p>\n Omega-6 fatty acids drive the inflammatory side of the immune response; omega-3 fatty acids drive the anti-inflammatory, healing side.<\/strong> Both are essential and both are needed. The problem with a modern diet is the proportion: omega-6 is present in very large amounts, and omega-3 often only in traces. An immune system built from that mixture is weighted towards inflammation before anything else has gone wrong.<\/p>\n The working target here is a ratio of about 1:1<\/strong>, with around 1:4<\/strong> generally acceptable. Trans fats and hydrogenated fats push the same balance the wrong way, and excess body fat does too \u2014 which is one reason body composition is treated as a clinical measurement in this practice rather than a cosmetic one.<\/p>\n \u26a0\ufe0f One caution that is easy to get wrong.<\/strong> Omega-3 is a fragile fat, and simply eating large quantities of high omega-3 seeds is not the answer and can do harm. It has to arrive alongside the antioxidants and micronutrients that protect it \u2014 zinc, selenium, the B-complex vitamins and the rest. Correcting one nutrient in isolation is not a correction.<\/p>\n The body is built from what is put into it, and repair is not possible without the materials. The list is finite and it is known: oxygen, water, fourteen vitamins, fourteen minerals, around twenty amino acids, four fatty acids, sugars, starch and dietary fibre.<\/strong><\/p>\n Nutrition here means supplying that full range, in a form dense enough to deliver it and clean enough not to add to the load. It does not mean a general instruction to eat healthily, and it does not mean supplementing whatever happens to be fashionable. In a disease where the skin is being rebuilt every few days and the joints are inflamed, the raw materials for repair are not optional.<\/p>\n The treatment ladder in psoriasis is well established and it works. It should be described fairly.<\/p>\n What every one of them has in common is that they suppress or modulate the immune system<\/strong>. That is the mechanism, and it is why they work. It is also why the disease returns when they stop.<\/p>\n There is a fact about this class of drug that patients are rarely told and should be. Several of them are cancer drugs.<\/strong> Methotrexate is an antimetabolite used in oncology; a number of the immune-modulating agents are the same molecules used in cancer immunotherapy. That is not an argument against them \u2014 it is an argument for knowing what is being taken and why.<\/p>\n The trade-offs are real. Long-term steroids bring weight gain and diabetes, and diabetes brings its own prescription and the rest of the metabolic cascade with it. Methotrexate suppresses the bone marrow, and a falling white cell count is a finding that needs acting on. Long-term use has been associated with effects on the eyes. And there is a list of medicines \u2014 some antihypertensives, antimalarials and others \u2014 that can induce or worsen psoriasis<\/strong>: if lesions appear while a new drug is being taken, the drug itself is worth questioning.<\/p>\n The alternative aim is not suppression but balance<\/strong> \u2014 reducing what is provoking the immune system, and supplying what the healing half needs, so that the defensive half is not required to run so hot. That is a slower idea than an injection, and it is the one that does not have to continue forever.<\/p>\n Almost nobody with long-standing psoriasis has only psoriasis.<\/p>\n On scanning, the large majority of these patients are found to have fatty liver<\/strong>. On blood testing, many are already insulin resistant \u2014 the fasting sugar may be normal while the insulin is high, which is pre-diabetes whether or not it has been called that. Triglycerides and cholesterol are commonly raised. Overweight or frank obesity is usual. Kidney function is sometimes affected. And in patients on long-term treatment, some of this is the treatment’s doing rather than the disease’s.<\/p>\n What is repeatedly seen here is that when the underlying inflammation is corrected, these move at the same time \u2014 not as a pleasant side effect, but because they were sitting on the same foundation. That is the argument for treating the body rather than the lesion, and it is why a patient who arrives about their skin should have their liver, their sugar and their joints looked at on the same day.<\/p>\n What follows is one patient, described to show how the pieces move together. It is not a typical result and is not offered as one \u2014 what any individual can expect depends on how much capacity the body still has to repair.<\/p>\n She arrived carrying most of what this article has described, at once: psoriasis of long standing, psoriatic arthritis, diabetes needing daily insulin, high blood pressure, and \u2014 the part nobody expects on a psoriasis list \u2014 corneal ulceration, under ophthalmology care, with the sight in that eye largely gone. She was on methotrexate, and her rheumatologist had advised moving to a biologic, at a cost per injection running into tens of thousands of rupees.<\/p>\n The insulin was the first thing to become unnecessary, and it stopped on the first day, with the sugars settling within a day or two. The oral medicines came down over the following weeks as symptoms settled and repeat reports allowed it, and within about a month she was off them. The joints and the skin had settled in that time. The steroid eye drops were reduced last and most slowly, because an eye under active treatment is not something to hurry.<\/p>\n What was not expected was the eye. The vision came back.<\/strong> What did not come back was the scarring already formed on the outer part of the cornea \u2014 that is structural, and it stayed. So the honest summary is that the active disease settled across four conditions at once, and the one thing already destroyed remained destroyed.<\/p>\n That is the argument of this article in a single patient. Nobody set out to treat her eye.<\/p>\n The ranking below is from clinical experience in this practice, not from trial data, and is offered in that spirit.<\/p>\n Most<\/strong> \u2014 psoriasis of any extent where the joints are not yet deformed, particularly alongside fatty liver, insulin resistance or excess weight. Severity of the skin is not the barrier people assume it to be; very extensive disease often responds well, and the patient carrying three or four conditions at once has the most to gain, because one effort addresses all of them.<\/p>\n Substantial<\/strong> \u2014 psoriatic arthritis before erosion has occurred, nail disease, and patients on long-term methotrexate, steroids or biologics who want to reduce what they are taking. Scalp and flexural disease respond.<\/p>\n Real, but bounded<\/strong> \u2014 where joints are already deformed or bone already eroded, and where scarring has formed. The active disease can settle; the structure does not come back. Function and pain still improve, and that is worth having.<\/p>\n Least<\/strong> \u2014 established kidney failure. Here the work is supportive at best, and the honest answer is that this is not the treatment for it.<\/p>\n Two timelines run in parallel, and confusing them is the commonest source of disappointment.<\/p>\n Symptomatic relief comes early<\/strong> \u2014 often within days. The itching settles, and with it the sleep. Patients who have not slept properly for weeks because of the itching frequently report a full night within the first day or two, and that alone changes what the rest is like.<\/p>\n The skin takes about a month<\/strong>, because that is how long the skin’s own cycle is. Meaningful clearing at thirty days, with continued improvement after it, is the realistic expectation. Anyone promising a cleared skin in a week is describing a drug effect, not a repair.<\/p>\n The joints move on their own schedule<\/strong>, generally with the inflammatory markers rather than with the skin.<\/p>\n Monitoring is weekly at first \u2014 inflammatory markers, the blood count, and whatever else the individual case requires \u2014 then fortnightly, then monthly. The purpose of measuring that often is not reassurance. It is that the medication reduction depends on it, and reducing medication on the basis of how somebody feels is not safe.<\/p>\n Nobody is asked to stop a medicine in order to start this. The sequence is the other way round.<\/p>\n Relief comes first.<\/strong> Where a patient is in real distress \u2014 heavy exfoliation, severe itching, an inflamed joint \u2014 a short course for symptomatic relief is part of the treatment and not a defeat. Correction runs alongside it. Then, as the symptoms settle and repeat testing confirms the change, the medicines come down.<\/p>\n The tapering is gradual, doctor-led and driven by the reports. Methotrexate, for example, is stepped down in stages with the symptoms and the blood count checked at each step, rather than stopped. Where the blood count is already low because of the drug, that is a reason to reduce it sooner rather than later \u2014 and the count characteristically recovers as the dose falls and the nutrition improves. Steroid drops and topical steroids come down last and slowest, particularly where an eye is involved.<\/p>\n Depending on the patient’s condition, coming off the medicines takes somewhere between one and three months.<\/strong> Some come off all of them; some do not, and reducing to the smallest effective dose is a real result in itself.<\/p>\n Stress provokes a flare. The flare causes itching. The itching destroys sleep. Poor sleep raises inflammation, which provokes the next flare. It is a genuine loop, and it can be entered from any point \u2014 which also means it can be interrupted from any point.<\/p>\n Sleep is treated as clinical, not incidental. The immune system does much of its repair during sleep. Melatonin is released in darkness, so screens late at night are not a lifestyle quibble but a direct interference with the mechanism. The approach here is to restore the rhythm rather than to prescribe something to induce it.<\/p>\n The toxin load is worth taking seriously and is largely within a patient’s control. Food colourings, preservatives and taste enhancers; food that has travelled across the world and been treated to survive the journey; detergent residue in clothing worn against inflamed skin \u2014 rinsing several times, and preferring plain cotton, is a small thing that patients notice; perfumes and cosmetics applied to broken skin; hot food served in plastic. None of these is the cause of psoriasis. All of them add to a load that an overactive immune system is already struggling with.<\/p>\n The most useful single instruction is also the simplest: reduce the number of ingredients.<\/strong> Eat food with few components in it, and it becomes possible to identify what actually provokes a reaction \u2014 which cannot be done while fifty ingredients are arriving at once.<\/p>\n\n
Psoriasis is not a skin disease<\/h2>\n
![\"Diagram](\"https:\/\/www.lcchospital.com\/wp-content\/uploads\/2026\/08\/cslc-cap-psoriasis-not-a-skin-disease.png\")
Why psoriatic arthritis often comes first<\/h2>\n
Inheriting a tendency is not inheriting the disease<\/h2>\n
What is actually happening: two halves of one system<\/h2>\n
![\"Two-part](\"https:\/\/www.lcchospital.com\/wp-content\/uploads\/2026\/08\/cslc-cap-psoriasis-immune-balance-turnover.png\")
The gut comes first<\/h2>\n
The fats, and why they decide inflammation<\/h2>\n
The fifty-seven<\/h2>\n
What the medicines do \u2014 suppress, or modulate<\/h2>\n
\n
When several conditions travel together<\/h2>\n
One patient’s course<\/h2>\n
Where this does most, and where it does least<\/h2>\n
![\"Ranking](\"https:\/\/www.lcchospital.com\/wp-content\/uploads\/2026\/08\/cslc-cap-psoriasis-where-it-helps.png\")
What patients experience, and when<\/h2>\n
Medication \u2014 how reduction actually happens<\/h2>\n
Toxins, sleep and the flare cycle<\/h2>\n
The four optimization domains<\/h2>\n
\n\n
\n \nDomain<\/th>\n What it addresses<\/th>\n<\/tr>\n<\/thead>\n \n Optimal nutrition<\/td>\n Supplying the full range of nutrients the body needs in order to repair \u2014 oxygen and water, fourteen vitamins, fourteen minerals, around twenty amino acids, four fatty acids and dietary fibre \u2014 in a nutrient-dense form with minimal additives. In psoriasis the balance of fats is not general advice but acts on the mechanism itself, and omega-3 is supplied alongside the antioxidants and minerals that protect it rather than on its own.<\/td>\n<\/tr>\n \n Optimal exercise<\/td>\n Gentle, segmental movement performed lying down and then sitting, working through the body part by part in a set order \u2014 around 650 muscles, activated systematically, and graded to what the person can manage. No gym or equipment is involved, so it remains possible when joints are painful and swollen, which is exactly when conventional exercise advice fails.<\/td>\n<\/tr>\n \n Rest and sleep<\/td>\n Recovery, without which repair does not function well however good the nutrition. The immune system does much of its repair during sleep, and in psoriasis sleep is often the first thing the disease takes away.<\/td>\n<\/tr>\n \n Reduced toxin load<\/td>\n Lowering avoidable exposure \u2014 food additives, preservatives and colourings first, then detergents and cosmetics reaching inflamed skin, then alcohol and tobacco. Excess body fat and excess circulating glucose are treated as part of the same load, because the body handles them the same way.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n